4(1H)-Pyrimidinone, 2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-, 98%, 250mg

Benzyloxyacetic acid, 97.0%, 100g

Pipettes graduées type 3 classe B, 5 ml, Division, 0,05 ml, Extrémité avec bouchon en coton, oui, 12 pièces

8-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95%, 5g

4-Acetylbenzo[d]oxazol-2(3H)-one, 95.0%, 100mg

1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)piperazine, 97.0%, 1g

8-Bromo-5-methylimidazo[1,2-a]pyridine, 97%, 1g

(2E)-3-(3-fluorophenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

Fmoc-D-Asp(OtBu)-OH, 98%, 100g

3-Vinyl-7-oxabicyclo[4.1.0]heptane, 95.0%, 25g

4-Phenylthiophene-2-carbaldehyde, 97.0%, 5g

2-Oxoindoline-3-carbaldehyde, 97.0%, 250mg

6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide 2,2,2-trifluoroacetate, 95.0%, 1g